Report Company Directory
- Terminating coverage: ALGN, AVNS, DXCM, GKOS, INSP, PODD, XENT, MASI, NNOX, TNDM, CHNG, PINC by Berenberg
- MedTech Recap and Preview: EW Investor Day is a 'Win'; MDT Cranial & Spine Update; JNJ ASH Updates; Inpatient Vol at 2021 Highs; S. Africa Hosp Trend Update by Credit Suisse
- MedTech Recap and Preview: EW Investor Day on Deck: Expecting Solid 2022 TAVR Guide; US Inpatient Util Bounces Back; Initial Analysis of S. Africa Data is Encouraging by Credit Suisse
- MedTech Recap and Preview: Omicron Variant in Focus; MDT Clearing Event Scuttled by Reduced Robot Outlook; COVID Hosps Rise But at Slower Pace by Credit Suisse
- MedTech Recap and Preview: MDT On Deck, Mixed Results and Guide Appear Discounted; JNJ Pharma and SYK Investor Updates Raise LT Growth and EPS Goals by Credit Suisse
- MedTech Recap and Preview: Q3 Earnings End with Mixed Results and Commentary; Rising COVID Hospitalizations and Elevated Staffing Risks Raise Concerns by Credit Suisse
- MedTech Recap and Preview: CS Annual Healthcare Conference and Week 4 Med Tech Earnings; TCT is Muted But Positive, Encouraging for Tricuspid by Credit Suisse
- MedTech Recap and Preview: Week 3 Earnings for IART, GMED & ZBH: Expect Q3 Softness and Potential Cuts to Guidance; SMISS Takes: Pos for NUVA, Neg for Staffing by Credit Suisse
- MedTech Recap and Preview: Week 2 Earnings: BSX, EW, BAX and SYK - Q3 Softness Discounted, Expecting Further Supportive Comments on Recovery by Credit Suisse
- Intersect ENT (XENT US) - Medtronic to purchase XENT for $28.25/share by Berenberg